CBAT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 91 industry peers in the Electrical Equipment industry. CBAT may be in some trouble as it scores bad on both profitability and health. CBAT is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year CBAT has reported negative net income.
CBAT had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CBAT reported negative net income in multiple years.
In multiple years CBAT reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -1.79%, CBAT is in the better half of the industry, outperforming 62.64% of the companies in the same industry.
With a decent Return On Equity value of -5.36%, CBAT is doing good in the industry, outperforming 63.74% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-1.79%
ROE	-5.36%
ROIC	N/A

ROA(3y)-0.27%

ROA(5y)3.43%

ROE(3y)-0.16%

ROE(5y)6.15%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

CBAT's Profit Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 14.07%, CBAT is doing worse than 64.84% of the companies in the same industry.
In the last couple of years the Gross Margin of CBAT has grown nicely.
CBAT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	14.07%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y-61.47%

PM growth 5YN/A

GM growth 3Y32.43%

GM growth 5Y33.2%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CBAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CBAT has about the same amount of shares outstanding.
The number of shares outstanding for CBAT has been increased compared to 5 years ago.
The debt/assets ratio for CBAT has been reduced compared to a year ago.

2.2 Solvency

CBAT has an Altman-Z score of -0.18. This is a bad value and indicates that CBAT is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.18, CBAT is in line with its industry, outperforming 47.25% of the companies in the same industry.
CBAT has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
CBAT has a Debt to Equity ratio of 0.29. This is in the better half of the industry: CBAT outperforms 60.44% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.29
Debt/FCF	N/A
Altman-Z	-0.18

ROIC/WACCN/A

WACC5.67%

2.3 Liquidity

CBAT has a Current Ratio of 0.69. This is a bad value and indicates that CBAT is not financially healthy enough and could expect problems in meeting its short term obligations.
CBAT has a worse Current ratio (0.69) than 82.42% of its industry peers.
A Quick Ratio of 0.54 indicates that CBAT may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.54, CBAT is doing worse than 78.02% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	0.69
Quick Ratio	0.54

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for CBAT have decreased strongly by -141.18% in the last year.
The earnings per share for CBAT have been decreasing by -42.83% on average. This is quite bad
Looking at the last year, CBAT shows a very negative growth in Revenue. The Revenue has decreased by -22.02% in the last year.
CBAT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 51.40% yearly.

EPS 1Y (TTM)-141.18%

EPS 3Y-42.83%

EPS 5YN/A

EPS Q2Q%N/A

Revenue 1Y (TTM)-22.02%

Revenue growth 3Y49.65%

Revenue growth 5Y51.4%

Sales Q2Q%36.52%

3.2 Future

The Earnings Per Share is expected to decrease by -11.42% on average over the next years. This is quite bad
Based on estimates for the next years, CBAT will show a very strong growth in Revenue. The Revenue will grow by 30.48% on average per year.

EPS Next Y-139.23%

EPS Next 2Y-11.42%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-0.19%

Revenue Next 2Y30.48%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CBAT. In the last year negative earnings were reported.
CBAT is valuated reasonably with a Price/Forward Earnings ratio of 8.18.
Based on the Price/Forward Earnings ratio, CBAT is valued cheaper than 96.70% of the companies in the same industry.
CBAT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.98.